Global Radiopharmaceuticals Market Report: 2025-2030
According to MarkNtel Advisors recent report “Global Radiopharmaceuticals Market”. The report takes a numbers-based approach, breaking down precise data in a straightforward way. It consists of information on all the periods – past, present, and future. The report covers important topics like customer behavior, industry size, share, ongoing trends, market segments, and leading companies, and other valuable aspects related to the industry.
Key Highlights of the Report
- Market Outlook (2025-2030)
- Market Drivers and Challenges
- Competitive Benchmarking
Download Report Free Sample: – https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html
Radiopharmaceuticals Market Overview
The Global Radiopharmaceuticals Market size was valued at around USD 7.11 billion in 2024 and is projected to reach USD 12.73 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.19% during the forecast period, i.e., 2025-30. With the increasing burden of the geriatric population, the incidence of multiple diseases, including cancer, cardiovascular diseases (CVDs), etc., is expected to increase enormously across the world.
Radiopharmaceuticals Industry Trends
Increasing Quest for New Radioisotopes & Radiopharmaceuticals
- Driven by several limitations associated with the production of certain alpha-emitting isotopes, currently utilized in radiopharmaceuticals, the biopharma companies have begun to explore alternative radioisotopes, such as 211At, 223Radium, etc. For instance, in 2024, Novartis AG started a phase I study of [177Lu]Lu-FF58 in patients with advanced solid tumors. The newer radioisotopes tend to have intriguing opportunities for both imaging and therapy while potentially overcoming existing limitations. Further, coupled with an increase in cancer cases globally, the critical need to reduce the risks associated with conventional radiation therapy, has led to the exploration of newer radiopharmaceuticals. This, in turn, is expected to further drive the Global Radiopharmaceuticals Market during the forecasting years.
For Customized Report Inquiry: – https://www.marknteladvisors.com/query/request-customization/radiopharmaceuticals-market.html
Radiopharmaceuticals Market Segmentation
By Radioisotope
> Technetium 99- Market Size & Forecast 2019-2030, USD Million
> Fluorine 18- Market Size & Forecast 2019-2030, USD Million
> Iodine 131- Market Size & Forecast 2019-2030, USD Million
> Gallium 68- Market Size & Forecast 2019-2030, USD Million
> Iodine 123- Market Size & Forecast 2019-2030, USD Million
> Others (Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2019-2030, USD Million
By Indication
> Oncology- Market Size & Forecast 2019-2030, USD Million
> Cardiology- Market Size & Forecast 2019-2030, USD Million
> Gastroenterology- Market Size & Forecast 2019-2030, USD Million
> Nephrology- Market Size & Forecast 2019-2030, USD Million
> Others (Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2019-2030, USD Million
By Type
> Diagnostic- Market Size & Forecast 2019-2030, USD Million
> Therapeutic- Market Size & Forecast 2019-2030, USD Million
By End User
> Hospitals- Market Size & Forecast 2019-2030, USD Million
> Medical Imaging Centers- Market Size & Forecast 2019-2030, USD Million
> Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2019-2030, USD Million
Geographical Insights:
- North America
- Europe
- Asia Pacific
- Middle East/Africa
- South America
Competitive Landscape
The competitive landscape of the market has been studied in the report with detailed profiles of key players operating in the Radiopharmaceuticals market.
Key Players
- > Bayer AG
- > Iso-Tex Diagnostics, Inc.
- > Jubilant Pharmova Limited
- > Novartis AG
- > General Electric Company
- > Lantheus Holdings, Inc.
- > Eli Lilly and Company
- > Siemens Healthineers AG
- > Curium Pharma
- > Cardinal Health
- > Blue Earth Diagnostics, Inc. (Bracco Group)
- > Acrotech Biopharm
- > Northstar Medical Technologies LLC
- > IBA Radiopharma Solutions
- > Sun Pharmaceutical Industries, Inc.
For Purchase Enquiry or Further Discussion: – https://www.marknteladvisors.com/query/talk-to-our-consultant/radiopharmaceuticals-market.html
Why This Report:
- Strategic Insights: These reports aid strategic decision-making for multinational corporations, financial institutions, and governments by providing crucial market insights.
- Global Perspective: With a presence in 80+ countries, the reports offer a comprehensive view of the global market landscape, facilitating informed decision-making on both regional and international scales.
- Expertise in Niche Industries: The specialized team’s expertise in niche industries and emerging geographies allows for detailed and accurate market analysis, vital for informed decision-making.
- Integrated Strategic Parameters: Covering strategic parameters such as Go-to-Market strategies, product development, and trend analysis empowers clients to develop tailored and informed strategies.
- Identifying Growth Opportunities: The reports enable clients to identify investment opportunities, emerging market trends, and white spaces, aiding in maximizing returns and gaining a competitive edge.
Other Report:
- https://uberant.com/article/2070890-europe-smart-water-meter-market-insights-opportunities-trends-demand-growth-outlook-2022-2027/
- https://uberant.com/article/2070888-germany-pet-food-market-investment-opportunities-where-to-focus-in-the-coming-decade/
- https://uberant.com/article/2070856-saudi-arabia-road-transport-refrigeration-equipment-market-trends-detailed-insights-on-size-share-and-growth-/
- https://uberant.com/article/2070785-uae-catering-services-market-in-depth-outlook-size-share-major-stakeholders/
- https://uberant.com/article/2070038-us-battle-management-system-market-insights-opportunities-trends-demand-growth-outlook-2023-2028/
About US:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
For Media Inquiries, Please Contact:
Phone: +1 628 895 8081 | +91 120 4278433
Email: [email protected]
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
